Performance of the Cardiac Microcurrent (C-MIC) System With a Less Invasively Placed Left Ventricular Lead

NARecruitingINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

April 9, 2025

Primary Completion Date

April 30, 2026

Study Completion Date

June 30, 2026

Conditions
Idiopathic CardiomyopathyLeft Ventricular (LV) Systolic Dysfunction
Interventions
DEVICE

Subcutaneous cardiac microcurrent treatment

An implantable device that emits a weak direct (DC)-microcurrent directly to the heart, using a coil electrode that is transvenously placed in the right ventricle and a patch electrode that is placed in a left thoracic subcutaneous pocket

DEVICE

Infraclavicular pocket cardiac microcurrent treatment

An implantable device that emits a weak direct (DC)-microcurrent directly to the heart, using a coil electrode that is transvenously placed in the right ventricle and a patch electrode that is placed in the same infraclavicular pocket as the device itself

DEVICE

Coronary Sinus cardiac microcurrent treatment

An implantable device that emits a weak direct (DC)-microcurrent directly to the heart, using a coil electrode that is transvenously placed in the right ventricle and a coronary sinus electrode

Trial Locations (2)

11040

RECRUITING

Institute of Cardiovascular Disease Dedinje, Belgrade

78000

NOT_YET_RECRUITING

University Clinical Center of the Republic of Srbska, Banja Luka

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

SCIRENT Clinical Research and Science d.o.o.

UNKNOWN

lead

Berlin Heals GmbH

INDUSTRY